🔗 Share this article Users Stopping Weight-Loss Jabs Regain Weight Four Times Faster Than Those on Conventional Diets Obesity treatment often requires ongoing approaches. A recent study suggests that individuals who stop using blockbuster weight-loss injections like semaglutide or tirzepatide may regain lost weight far faster than those who end traditional diet and exercise regimens. Findings released in a prominent medical journal shows that while overweight people frequently drop about a fifth of their body weight while undergoing treatment, the mass returns at an average rate of nearly a kilo each month upon discontinuation. "Users buying such medications must be cognizant of the potential of quick rebound weight gain when the treatment ends," stated expert Dr. Susan Jebb. Such speed of regain implies a return to starting weight in about 18 months. Analyzing Treatments The analysis, which looked at dozens of trials involving over 9,000 of patients, compared the effects of GLP-1 agonists with older methods. Researchers emphasize that people who lose weight through dieting usually experience a more gradual weight regain—perhaps 0.1 kg a month—once they finish. The Reason for the Quick Regain Experts suggest the mechanism of the jabs explains the accelerated weight return. The injections mimic a natural hormone called GLP-1, which helps regulate feelings of fullness. "Artificially providing the hormone concentrations several times higher than normal might result in the system to produce less of its endogenous hormone, and may also reduce responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher. "Withdrawal of this medication means appetite is unsuppressed, making binge eating much more probable." A Lifelong Condition? The NHS suggest the jabs for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications. A number of clinicians argue that, considering the likelihood of relapse, the therapy is often long-term. This view is reinforced by pharmaceutical companies, who state that the results "highlight the chronic nature of obesity," comparing it to managing conditions like hypertension. Patient Accounts People who have stopped the jabs report a powerful return of appetite. "I experienced a switch that goes on and you're instantly ravenous," said a patient. This challenge is exacerbated if individuals have not developed sustainable lifestyle or habit changes during treatment. Significant Interest Figures suggest that a significant number of people in the UK have used weight-loss jabs in the past year, with demand remaining high. Use is more common among women compared to men. The middle-aged demographic shows the highest usage rates. Many access the medications through private prescriptions rather than the NHS. In conclusion, experts caution that while the jabs are effective agents for shedding pounds, they are not a standalone cure and lasting health benefits likely depends on ongoing lifestyle changes.
Obesity treatment often requires ongoing approaches. A recent study suggests that individuals who stop using blockbuster weight-loss injections like semaglutide or tirzepatide may regain lost weight far faster than those who end traditional diet and exercise regimens. Findings released in a prominent medical journal shows that while overweight people frequently drop about a fifth of their body weight while undergoing treatment, the mass returns at an average rate of nearly a kilo each month upon discontinuation. "Users buying such medications must be cognizant of the potential of quick rebound weight gain when the treatment ends," stated expert Dr. Susan Jebb. Such speed of regain implies a return to starting weight in about 18 months. Analyzing Treatments The analysis, which looked at dozens of trials involving over 9,000 of patients, compared the effects of GLP-1 agonists with older methods. Researchers emphasize that people who lose weight through dieting usually experience a more gradual weight regain—perhaps 0.1 kg a month—once they finish. The Reason for the Quick Regain Experts suggest the mechanism of the jabs explains the accelerated weight return. The injections mimic a natural hormone called GLP-1, which helps regulate feelings of fullness. "Artificially providing the hormone concentrations several times higher than normal might result in the system to produce less of its endogenous hormone, and may also reduce responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher. "Withdrawal of this medication means appetite is unsuppressed, making binge eating much more probable." A Lifelong Condition? The NHS suggest the jabs for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications. A number of clinicians argue that, considering the likelihood of relapse, the therapy is often long-term. This view is reinforced by pharmaceutical companies, who state that the results "highlight the chronic nature of obesity," comparing it to managing conditions like hypertension. Patient Accounts People who have stopped the jabs report a powerful return of appetite. "I experienced a switch that goes on and you're instantly ravenous," said a patient. This challenge is exacerbated if individuals have not developed sustainable lifestyle or habit changes during treatment. Significant Interest Figures suggest that a significant number of people in the UK have used weight-loss jabs in the past year, with demand remaining high. Use is more common among women compared to men. The middle-aged demographic shows the highest usage rates. Many access the medications through private prescriptions rather than the NHS. In conclusion, experts caution that while the jabs are effective agents for shedding pounds, they are not a standalone cure and lasting health benefits likely depends on ongoing lifestyle changes.